会议为中性证券白名单会议仅限受邀客户参会未经中性证券和演讲嘉宾书面许可任何机构和个人不得以任何形式将会议内容和相关信息对外公布转发转载传播复制编辑修改等如有上述违法行为中性证券保留追究相关法律责任的权利 尊敬的各位投资者分析师大家下午好公司已于2024年11月26日刊登了关于投资3C石垒浮材料有限责任公司的公告为便于广大投资者更深入全面的了解公司向上游延伸投资布局石垒浮材料的战略特召开本次投资者交流会本次会议由公司主持并借用中信证券电话会议平台进行交流 参加会议的有星座班董事长宁九三先生董秘贺敬策先生接下来我们开始本次的交流会首先有请董秘贺敬策先生对投资情况做一个基本介绍介绍完后我们进行互动问答好的各位投资人下午好在过去的几年里电子业及材料行业发展迅速同时也看到资产价格的剧烈波动为保障关键原材料的稳定供应 公司一直在往账源材料布局650这里作为李林子电子电子业的关键材料其市场需求持续增长在竞争日益激烈的市场环境中目前众多同行通过仓库或者投资关键原材料以保账源材料的供应安全公司本次投资石蕾福材料有助于公司调整和优化供应商结构实现产业链的垂直整合 综而保证原材料供应的稳定性和安全性同时抓住市场机遇增强公司的竞争力 ...

Investment Overview - Shenzhen Xinzhoubang Technology Co., Ltd. has invested approximately 352 million CNY in Jiangxi Shilei Fluorine Materials Co., Ltd., acquiring a 42.8251% stake [2][3]. - The pre-investment valuation of Shilei Fluorine Materials was 470 million CNY [3]. Market Context - The electrolyte and materials industry has experienced rapid growth and significant price volatility in recent years [2]. - Lithium hexafluorophosphate, a key material for lithium-ion battery electrolytes, has seen continuous market demand growth [2]. Strategic Importance - The investment aims to optimize the supply chain and ensure stable raw material supply, enhancing the company's competitiveness [2][3]. - Shilei Fluorine Materials has a production capacity of 50,000 tons/year for anhydrous hydrogen fluoride and 15,000 tons/year for lithium hexafluorophosphate, indicating strong competitive capabilities [3]. Future Plans - Shilei Fluorine Materials plans to increase its overall compliant production capacity of lithium hexafluorophosphate to 33,000 tons/year by 2025, with capital expenditures not exceeding 150 million CNY [9]. - The company aims to implement further technological upgrades and expand production capacity to improve financial performance [4][9]. Quality Assurance - Shilei Fluorine Materials has obtained various quality certifications, including ISO9001, ISO14001, ISO45001, and IATF16949, ensuring high product quality [4]. Financial Performance - Shilei Fluorine Materials has faced losses in the past year due to intensified market competition and declining product prices, with a reported loss or marginal profit in the first nine months of 2024 [4][5]. - The company is actively working to improve production efficiency and reduce costs to enhance competitiveness [4]. Strategic Control - The decision not to acquire full control of Shilei Fluorine Materials respects the original controlling party's development intentions and aims for a win-win situation [5]. - The joint control structure allows for strategic influence while maintaining operational independence for Shilei Fluorine Materials [5].

Investment Rating - The report maintains a "Buy" rating for Shenzhen Capchem Technology Co Ltd (300037) [7][9] Core Views - The company plans to invest approximately 352 million yuan to increase its stake in Jiangxi Shilei Fluorine Materials Co Ltd, which will become a jointly controlled joint venture after the investment [3] - Jiangxi Shilei has a strong position in the lithium hexafluorophosphate (LiPF6) industry, with a current market share of 4.2% and plans to expand its capacity to 33,000 tons/year within three years [4] - The investment is strategically positioned at a low valuation, with potential cost advantages due to Jiangxi Shilei's innovative dynamic constant temperature crystallization technology [5] - The investment will enable Shenzhen Capchem to achieve a full industry chain layout in the electrolyte sector, from LiPF6 to solvents, additives, and electrolytes [6] - The company is expected to see significant profit growth, with projected net profits of 1.16 billion yuan, 1.86 billion yuan, and 2.49 billion yuan for 2024, 2025, and 2026, respectively [7] Financial Summary - Revenue is forecasted to grow from 7.48 billion yuan in 2023 to 16.87 billion yuan in 2026, with year-on-year growth rates of 31.46%, 33.54%, and 28.40% for 2024, 2025, and 2026, respectively [8] - Net profit attributable to shareholders is expected to increase from 1.01 billion yuan in 2023 to 2.49 billion yuan in 2026, with growth rates of 15.02%, 59.81%, and 34.13% for the respective years [8] - The company's PE ratio is projected to decrease from 27.51 in 2024 to 12.84 in 2026, indicating improving valuation metrics [8] Industry and Market Position - Jiangxi Shilei is positioned in the second tier of the global LiPF6 industry, with a current effective global capacity of approximately 360,000 tons in 2023 [4] - The company benefits from access to fluorite resources, with a long-term supply agreement for fluorite concentrate from its parent company, Shilei Group [4] - The LiPF6 market has shown signs of recovery, with prices rising by approximately 4,000 yuan to 58,500 yuan/ton, which could enhance the company's profitability if the electrolyte industry continues to improve [6]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is investing 352 million yuan to acquire a 42% stake in Jiangxi Shilei, which is expected to enhance profit elasticity from hexafluorophosphate [2] - Jiangxi Shilei has a current capacity of 15,000 tons of hexafluorophosphate and a long-term supply agreement for raw materials, ensuring upstream material supply [2] - The company anticipates a cumulative net profit of no less than 267 million yuan during the performance commitment period from October 2024 to 2027 [3] - The company is positioned to benefit from potential price increases in hexafluorophosphate, which could significantly improve profitability [3] - The company forecasts net profits of 1.065 billion yuan, 1.442 billion yuan, and 2.012 billion yuan for 2024, 2025, and 2026 respectively, with corresponding P/E ratios of 30, 22, and 16 [4] Financial Projections - Total revenue is projected to be 8.328 billion yuan in 2024, with a year-on-year growth of 11.28% [1] - The company expects to achieve a net profit of 1.065 billion yuan in 2024, reflecting a 5.38% increase year-on-year [1] - The earnings per share (EPS) is estimated to be 1.41 yuan in 2024, with a projected increase to 2.67 yuan by 2026 [1] - The company maintains a strong competitive position in the fluorochemical industry, with a target price of 57 yuan based on a 30x P/E ratio for 2025 [4]

本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届监事会第十五次 会议于2024年11月24日以通讯方式召开。本次监事会会议通知已于2024年11月20 日以电子邮件方式发出。本次监事会应参与表决监事3人，实际参与表决监事3人， 公司董事会秘书贺靖策先生列席会议。会议由公司监事会主席张桂文女士召集并 主持。本次会议的召集、召开符合有关法律、法规和《公司章程》的规定。 经表决形成如下决议： 一、审议通过了《关于投资江西石磊氟材料有限责任公司的议案》 经审核，公司监事会认为：通过本次增资，公司得以多元化供应渠道，优化 供应商结构，同时完善电解液关键原材料产业布局。本次增资的资金来源为公司 自有资金，不会对公司本年度的财务及经营情况产生重大不利影响，不存在损害 公司和股东利益尤其是中小股东利益的情形，符合公司及全体股东的利益。监事 会一致同意《关于投资江西石磊氟材料有限责任公司的议案》。 | 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-084 | | --- | --- | --- | | ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-085 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于投资江西石磊氟材料有限责任公司的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 公司于 2024 年 11 月 24 日召开的第六届董事会第十六次会议，审议通过了 《关于投资江西石磊氟材料有限责任公司的议案》，根据《深圳证券交易所创业 1 板股票上市规则》、公司的《公司章程》等相关规定，本次增资事项未达到《深 圳证券交易所创业板股票上市规则》和公司《公司章程》规定的应当提交股东大 会审议标准，无需提交股东大会审议。 （三）不属于关联交易和重大资产重组事项的说明 本次增资的交易对手方与公司无关联关系，本次增资不构成关联交易，也不 构成《上市公司重大资产重组管理办法》规定的重大资产重组。 一、对外投资概述 （一）对外投资基本情况 深圳新宙邦科技股份有限公司（以下简称"新宙邦""公司"）拟与江西石磊氟 材料有限责任公司（以下简称"石磊氟材料""标 ...

深圳新宙邦科技股份有限公司 第六届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 | 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-083 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 经审核，公司董事会认为：通过本次增资，公司得以多元化供应渠道，优化 供应商结构，同时完善电解液关键原材料产业布局。公司董事会同意《关于投资 江西石磊氟材料有限责任公司的议案》，同意进一步授权公司董事长或其指定的 授权代理人，在不违背本次增资核心商业条件，不损害公司以及股东利益的前提 下，根据实际情况对本次增资的相关文件进行修改或补充，并授权管理层全权办 理后续一切事宜。 《关于投资江西石磊氟材料有限责任公司的公告》以及监事会发表意见具体 内容详见同日刊登在中国证监会指定的创业板信息披露网站巨潮资讯网。 本事项已经公司第六届董事会战略与可持续发展委员会审议通过。 表决结果：9 票同意，0 票反对，0 票弃权，获得通过。 特此公告。 1 深圳新宙邦科技股份有限公司董事会 深 ...

2024年第四次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会不存在增加、变更、否决议案的情况； 2、本次股东大会不涉及变更前次股东大会决议的情况； 3、本次股东大会以现场与网络投票相结合的方式召开。 一、会议召开和出席情况 | 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-082 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 1、现场会议召开时间：2024 年 11 月 14 日（星期四）14:00 2、网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为2024年11月14日9： 15—9：25，9：30—11:30和13：00—15：00。 通过深圳证券交易所互联网投票系统投票的具体时间为2024年11月14日9： 15至15：00任意时间。 3、现场会议召开地点：深圳市坪山区昌业路新宙邦科技大厦 16 层会议室 4、会议召集人：公司第六届董事会 5、会议主持人：董事周达文先生 注 ...

北京市中伦（深圳）律师事务所 关于深圳新宙邦科技股份有限公司 2024 年第四次临时股东大会的 法律意见书 二〇二四年十一月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 法律意见书 北京市中伦（深圳）律师事务所 关于深圳新宙邦科技股份有限公司 2024 年第四次临时股东大会的 法律意见书 致：深圳新宙邦科技股份有限公司 根据《中华人民共和国公司法》（下称"《公司法》"）、《上市公司股东大 会规则》（下称"《股东大会规则》"）和《深圳新宙邦科技股份有限公司章程》 （下称"《公司章程》"）的规定，北京 ...

Investment Rating - The report maintains a rating of "Accumulate" for the company [1][3]. Core Views - The company reported a significant increase in shipment volume and is actively expanding its international market presence, despite a year-on-year profit decline of 12% in the first three quarters of 2024 [3]. - The company's Q3 2024 profit increased by 13.91% quarter-on-quarter, with a net profit of 286 million RMB [3]. - The battery chemical products experienced substantial growth in shipment volume, driven by the rapid increase in demand from the new energy vehicle and energy storage sectors, although profitability was pressured by intensified domestic market competition [3]. - The fluorochemical business showed steady growth, with the second phase of the Haise fluorochemical project fully operational and expected to continue growing in 2025 [3]. - The overseas project in Poland has been performing well since its launch in 2023, with a production capacity of 40,000 tons effectively meeting European and American customer demands [3]. Financial Summary - For the first three quarters of 2024, the company achieved a total profit of 701 million RMB, with a gross profit margin of 27.09%, down 2.83 percentage points year-on-year [3][5]. - The forecasted earnings per share (EPS) for 2024-2026 have been adjusted to 1.40, 1.93, and 2.50 RMB, respectively, reflecting a decrease from previous estimates [3][4]. - The company's total revenue for 2024 is projected to be 8,661 million RMB, representing a growth rate of 15.7% [4][6]. - The net profit for 2024 is expected to be 1,057 million RMB, with a growth rate of 4.5% [4][6].